PrecisionTOX and the Push for Human-Relevant Testing
Why Human-Relevant Testing Matters at PrecisionTOX
Traditional toxicology has long relied on animal models that often fail to predict human responses. PrecisionTOX, a partner within the ASPIS cluster, addresses this gap by building cell-based and computational tools that mirror real human biology. The goal is not simply to replace animals, but to produce data that regulators and innovators can trust.
By focusing on human cells, organoids, and advanced in silico models, PrecisionTOX helps identify hazards earlier and with greater accuracy. This approach reduces late-stage failures and supports the development of safer chemicals, drugs, and consumer products.
Cell-Based Systems That Reflect Human Physiology
PrecisionTOX develops human cell-based assays that capture key biological pathways. These include primary cells, induced pluripotent stem cell-derived models, and three-dimensional organoids that mimic organ-level responses. Unlike immortalized cell lines, these systems retain donor-specific genetics and metabolic competence.
The team also integrates microphysiological systems, often called organ-on-a-chip platforms, to recreate tissue interfaces and fluid flow. Such models allow researchers to study absorption, distribution, metabolism, and excretion in a human-relevant context.
- Human primary hepatocytes for metabolic and toxicity studies
- Kidney proximal tubule models for nephrotoxicity screening
- Cardiac microtissues for arrhythmia and contractility assessment
- Immune-competent co-cultures for sensitization and inflammation
Computational Tools for Predictive Toxicology
Alongside wet-lab work, PrecisionTOX builds computational models that translate biological data into predictions. These include quantitative structure-activity relationship models, read-across frameworks, and machine learning classifiers trained on human-relevant endpoints.
The computational suite is designed to be transparent and reproducible. Each model documents its training data, assumptions, and applicability domain, which is essential for regulatory acceptance.
- Curate high-quality human toxicogenomic datasets
- Train and validate machine learning models
- Map predictions to adverse outcome pathways
- Publish tools with open documentation and version control
Integrating Evidence for Regulatory Confidence
PrecisionTOX does not treat cell-based and computational methods as separate silos. Instead, it combines them into integrated approaches to testing and assessment. This means evidence from multiple human-relevant sources is weighed together to reach a conclusion.
We want every prediction to be traceable to human biology, not to an animal surrogate that may mislead us.
This integration supports next-generation risk assessment, where mechanistic understanding and exposure data inform safety decisions. It also aligns with the ASPIS cluster's mission to advance non-animal methods across Europe and beyond.
Looking Ahead with PrecisionTOX and ASPIS
The push for human-relevant testing is not a single experiment but a continuous cycle of development, validation, and refinement. PrecisionTOX contributes by sharing protocols, data, and models with the wider ASPIS community.
As regulatory frameworks evolve, tools that reflect real human biology will become the standard. PrecisionTOX is helping to build that future, one cell-based assay and one computational model at a time.
